Causaly has launched new AI agents in its Causaly Discover platform, designed to help scientists tackle complex biomedical questions more quickly and accurately than ever before. This advanced AI technology enables research teams to access a vast array of biomedical knowledge, facilitating drug discovery. Scientists can save significant time—up to 90%—in identifying and validating research targets, streamlining the drug development process. Causaly’s platform integrates multiple data sources, allowing for better insights and collaboration among researchers. With features that help answer intricate questions in minutes and provide easily traceable insights, Causaly Discover is set to transform the pharmaceutical research landscape, making the drug discovery process faster and more effective.
Causaly has launched new AI agents in Causaly Discover, designed to help scientists tackle complex biomedical queries quickly and accurately by utilizing an extensive array of sources.
LONDON, March 31, 2025 /PRNewswire/ — Causaly is transforming the landscape of scientific research with its latest offering, Causaly Discover, which equips research teams with the most comprehensive biomedical knowledge available for drug discovery. By employing agentic AI, life sciences professionals can seamlessly access, analyze, and synthesize information from the Causaly Discover platform and various internal and external data sources. This will enable them to address their research inquiries with unparalleled speed and accuracy.
Having been developed over seven years, Causaly stands as the most sophisticated AI platform crafted for scientific discovery. Its cutting-edge search algorithms interconnect 500 million facts and 70 million relationships, streamlining the research process significantly. Scientists report that this platform allows them to save up to 90% of the time previously spent on identifying and validating targets for effective therapy development. Leading biopharmaceutical firms, such as Novo Nordisk, utilize Causaly to enhance their research capabilities and accelerate drug discovery.
“We are redefining drug discovery,” stated Yiannis Kiachopoulos, co-founder and CEO of Causaly. “Causaly Discover acts as a central hub, providing researchers with all necessary information to expedite therapies to Market. The newly introduced AI agents offer deeper insights that enable scientists to transition swiftly from inquiries to confident decisions.”
The expenses of developing a new drug can easily exceed $2 billion, with the overall process from discovery to launch taking over a decade. Identifying the right research targets early can greatly improve efficiency in this lengthy process.
Causaly’s AI agents are specifically tailored for life sciences, allowing researchers to sift through vast amounts of biomedical information more effectively. With the capability to:
- Resolve complex biomedical questions in minutes, instead of weeks
- Automatically create thorough reports to facilitate insight reviews
- Integrate external resources like Human Protein Atlas easily
All insights from Causaly Discover are completely traceable and derived from credible sources, enabling easy verification of results. This AI tool also allows for natural language queries, simplifying follow-up inquiries through Causaly Copilot. Teams can collaborate within a singular workspace by saving, sharing, and commenting on findings, with automated alerts keeping them updated on the latest evidence.
The new AI agents in Causaly Discover are currently available in early access and are set for general availability in May 2025. To discover how Causaly Discover can enhance scientific research by refining, verifying, and sharing insights more accurately, check out our blog.
Causaly is at the forefront of AI innovation in the life sciences sector. High-profile pharmaceutical companies utilize the Causaly AI platform to discover, visualize, and interpret biomedical information while automating essential research workflows. Learn how Causaly is speeding up drug discovery and facilitating essential treatments to reach patients promptly at www.causaly.com.
What is Causaly’s Agentic AI?
Causaly’s Agentic AI is a new artificial intelligence tool designed to help researchers find scientific information more easily. It helps discover connections in research data faster and more efficiently.
How does Agentic AI help in scientific discovery?
Agentic AI aids scientists by analyzing large amounts of data quickly. It identifies important patterns and relationships, which helps researchers make new discoveries or validate existing ones.
Who can use Agentic AI?
Agentic AI is mainly aimed at researchers, scientists, and academics in various fields like biology, medicine, and chemistry. Anyone looking for scientific information can benefit from its capabilities.
What are the main benefits of using Causaly’s Agentic AI?
The main benefits include faster data analysis, improved access to relevant information, and the ability to make new connections in research. This can lead to quicker breakthroughs and better decisions in scientific projects.
Is Causaly’s Agentic AI easy to use?
Yes, Agentic AI is designed to be user-friendly. Researchers do not need extensive technical skills to use it. The tool is built to help users efficiently navigate through scientific data and findings.
